Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments

BACKGROUND: Some, but not all, prior investigations suggest armodafinil may have utility as an adjunctive treatment in bipolar I depression. METHODS: Multicenter, randomized, double-blind study in patients aged 18 to 65 years experiencing a depressive episode despite maintenance therapy for bipolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Frye, Mark A, Amchin, Jess, Bauer, Michael, Adler, Caleb, Yang, Ronghua, Ketter, Terence A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556715/
https://www.ncbi.nlm.nih.gov/pubmed/26330288
http://dx.doi.org/10.1186/s40345-015-0034-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556715/
https://www.ncbi.nlm.nih.gov/pubmed/26330288
http://dx.doi.org/10.1186/s40345-015-0034-0

Ejemplares similares